Latin America Coagulation Testing Market Chromogenic and Immunodiagnostic Hemostasis Tests Latest Technologies Instrumentation Pipeline
The report is available in Local PDF, Global PDF, and Data Pack formats (supplier shares, test volumes, sales forecasts). The report is delivered in both Excel and PDF.
This new 22-country report from is available by country, market segment, section, or individual test.
The report explores business and technological trends; provides test volume and sales forecasts for 40 hemostasis procedures; compares features of major analyzers; profiles leading market players; and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.
Rationale
The growing cost-containment pressures in major industrialized nations, coupled with continued technological advances in chromogenic substrates, monoclonal antibodies, immunoassays, molecular diagnostics, IT and laboratory automation will radically change the global coagulation diagnostics practice during the next five years.
New specific and sensitive markers of coagulation will be increasingly used on automated instrumentation. Coagulation testing will also become more standardized, offering opportunities for quality control products and services. Moreover, the continuing contraction of the hospital system and technological advances will facilitate decentralization of the coagulation testing closer to the patient, thus creating additional opportunities and challenges for suppliers.
Coagulation Tests Analyzed in the Report
Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrands Factor Fav/Ag, and others.
Country Analyses
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Competitive Assessments
- Extensive strategic profiles of major suppliers and emerging market entrants.
Current and Emerging Products
- Review of established and emerging procedures.
- Comparison of automated and semi-automated analyzers marketed by Diagnostica Stago, Helena, IL, Siemens, Sysmex and other suppliers.
Technology Review
- Analysis of current and emerging technologies and their potential market applications.
- Companies developing or marketing new technologies and products by test.
Strategic Recommendations
- Product development and business expansion opportunities with significant market appeal.
- Ideal product models with tentative prices and operating characteristics.
- Alternative market penetration strategies for instrument and reagent suppliers.
- Potential market entry barriers and risks.
II. Market Overview
III. Major Product Development Opportunities
IV. Design Criteria for Decentralized Testing Products
V. Alternative Market Penetration Strategies
VI. Potential Market Entry Barriers and Risks
VII. Market and Technology Overview
A. Major Routine and Special Coagulation Tests
1. Introduction
2. Activated Partial Thromboplastin Time (APTT)
3. Alpha-2 Antiplasmin
4. Antithrombin III
5. Bleeding Time
6. D-Dimer
7. Ethanol Flocculation Test
8. Euglobulin Lysis
9. Factor Assays
a. Introduction
b. Factor II
c. Factor V/Factor V Leiden
d. Factor VII
e. Factor VIII
f. Factor IX
g. Factor IXa
h. Factor X (Stuart Factor)
i. Factor Xa
j. Factor XI
k. Factor XII
l. Factor XIII
10. Fibrin Degradation Products
11. Fibrinogen
12. Heparin
13. Hirudin
14. Hypercoagulability and Thrombosis
15. Lipoprotein a
16. Plasmin
17. Plasminogen
18. Plasminogen Activator Inhibitor (PAI)
19. Platelet Function Tests
20. Platelet Aggregation
21. Proteins C and S
22. Prothrombin Fragment 1.2
23. Prothrombin Time (PT)
24. Reptilase Time
25. Thrombin Time
26. Tissue-Type Plasminogen Activator (t-PA)
27. Von Willebrands Factor
B. Coagulation Instrumentation Review: Centralized
And POC Testing Analyzers
C. Major Coagulation Testing Technologies
And Their Potential Applications
VIII. 22-Country Market Analyses: Market Size, Reagent and Instrument Sales Forecasts, Volume
Projections for 40 Procedures, Supplier Sales and Market Shares
IX. Competitive Assessments
The report provides strategic assessments of over 20 leading coagulation market
players and start-up companies with innovative technologies and
products, including:
Abbott
Beckman Coulter/Danaher
Becton Dickinson
Diagnostica Stago
Grifols
Helena Laboratories
IL/Werfen
Roche
Sekisui Diagnostics
Siemens Healthineers
Sysmex
Thermo Fisher, and others
List Of Tables
Argentina Coagulation Test VolumeForecasts by Procedure
Argentina Coagulation Diagnostics Market
by Product Category
Bolivia Coagulation Test Volume
Forecasts by Procedure
Bolivia Coagulation Diagnostics Market
by Product Category
Brazil Coagulation Test Volume
Forecasts by Procedure
Brazil Coagulation Diagnostics Market
by Product Category
Chile Coagulation Test Volume
Forecasts by Procedure
Chile Coagulation Diagnostics Market
by Product Category
Colombia Coagulation Test Volume
Forecasts by Procedure
Colombia Coagulation Diagnostics Market
by Product Category
Costa Rica Coagulation Test Volume
Forecasts by Procedure
Costa Rica Coagulation Diagnostics
Market by Product Category
Cuba Coagulation Test Volume
Forecasts by Procedure
Cuba Coagulation Diagnostics Market
by Product Category
Dominican Republic Coagulation Test Volume
Forecasts by Procedure
Dominican Republic Coagulation
Diagnostics Market by Product Category
Ecuador Coagulation Test Volume
Forecasts by Procedure
Ecuador Coagulation Diagnostics
Market by Product Category
El Salvador Coagulation Test Volume
Forecasts by Procedure
El Salvador Coagulation Diagnostics
Market by Product Category
Guatemala Coagulation Test Volume
Forecasts by Procedure
Guatemala Coagulation Diagnostics
Market by Product Category
Haiti Coagulation Test Volume
Forecasts by Procedure
Haiti Coagulation Diagnostics Market by
Product Category
Honduras Coagulation Test Volume
Forecasts by Procedure
Honduras Coagulation Diagnostics
Market by Product Category
Jamaica Coagulation Test Volume
Forecasts by Procedure
Jamaica Coagulation Diagnostics Market
by Product Category
Mexico Coagulation Test Volume
Forecasts by Procedure
Mexico Coagulation Diagnostics Market
by Product Category
Nicaragua Coagulation Test Volume
Forecasts by Procedure
Nicaragua Coagulation Diagnostics
Market by Product Category
Panama Coagulation Test Volume
Forecasts by Procedure
Panama Coagulation Diagnostics
Market by Product Category
Paraguay Coagulation Test Volume
Forecasts by Procedure
Paraguay Coagulation Diagnostics
Market by Product Category
Peru Coagulation Test Volume
Forecasts by Procedure
Peru Coagulation Diagnostics Market
by Product Category
Puerto Rico Coagulation Test Volume
Forecasts by Procedure
Puerto Rico Coagulation Diagnostics
Market by Product Category
Uruguay Coagulation Test Volume
Forecasts by Procedure
Uruguay Coagulation Diagnostics
Market by Product Category
Venezuela Coagulation Test Volume
Forecasts by Procedure
Venezuela Coagulation Diagnostics Market
by Product Category
Major Companies Developing or Marketing
Activated Clotting Time Tests
Major Companies Developing or
Marketing APTT Tests
Major Companies Developing or Marketing
Alpha-2 Antiplasmin Tests
Major Companies Developing or Marketing
Antithrombin III Tests
Major Companies Developing or
Marketing Bleeding Time Tests
Major Companies Developing or
Marketing D-dimer Tests
Major Companies Developing or
Marketing Factor Assays
Major Companies Developing or Marketing
Fibrin Degradation Product Tests
Major Companies Developing or
Marketing Fibrinogen Tests
Major Companies Developing or
Marketing Heparin Tests
Major Companies Developing or
Marketing Plasmin Tests
Major Companies Developing or
Marketing Plasminogen Tests
Major Companies Developing or
Marketing Plasminogen Activator
Inhibitor Tests
Major Companies Developing or Marketing
Platelet Aggregation Tests
Major Companies Developing or
Marketing Protein C Tests
Major Companies Developing or
Marketing Protein S Tests
Major Companies Developing or
Marketing PT Tests
Major Companies Developing or
Marketing Thrombin Time Tests
Major Companies Developing or
Marketing TPA Tests
Major Companies Developing or Marketing
Von Willebrands Factor Tests
Latin America Nucleic Acid Testing Market Opportunities in 22 Countries
Latin America Nucleic Acid Testing Market Opportunities in 22 CountriesThis new 22-country report is available by country, market segment, section, or individual test. The report is designed to help current
USD 14500 View ReportWhats Next for Latin America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market?
Whats Next for Latin America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketThe report is available by section, market segment, and can be customized to your specific information needs
USD 14500 View ReportLatin America Nucleic Acid Testing Market Opportunities in 22 Countries
Latin America Nucleic Acid Testing Market Opportunities in 22 CountriesThis new 22-country report is available by country, market segment, section, or individual test. The report is designed to help current
USD 14500 View ReportWhats Next for Latin America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics Market?
Whats Next for Latin America Genetic Diseases, Cancer, Forensic and Paternity Molecular Diagnostics MarketThe report is available by section, market segment, and can be customized to your specific information needs
USD 14500 View ReportFill The Form For Sample Request